Skip to content
Screener

Thermo Fisher Scientific TMO Life Sciences Solutions — Operating Income (Loss)

Other segment segments

Laboratory Products and Biopharma Services
$936M+13.3%
Analytical Instruments
$424M+30.5%
Specialty Diagnostics
$334M+8.8%

Similar metrics at other companies

Danaher logo
DHRLife Sciences — Operating Income (Loss)
$244M+202%
HWK
HWKNFood & Health Sciences — Operating Income (Loss)
$11.25M+2.6%
Brighthouse Financial logo
BHFLife — Operating Income (Loss)
-$4M+84.6%
HWK
HWKNFood and Health Sciences — Operating Income (Loss)
$8.59M-16.6%
Lincoln National logo
LNCLife Insurance — Operating Income (Loss)
$41M+356%
Broadcom Inc. logo
AVGOSemiconductor Solutions — Operating Income (Loss)
$9.28B+93.1%

Other financials

Income statement

See full
Revenue$12.0B—
Operating income$2.1B—
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$213.65B+26.0%
Enterprise value$248.77B+22.9%
P/E30.7×+4.9×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%—
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Thermo Fisher Scientific’s 8-K, filed July 23, 2026. Open the filing →

Filed
Jul 23, 2026, 6:04 AM EDT
Accession
0000097745-26-000138

FAQ

What is Thermo Fisher Scientific's life sciences solutions — operating income (loss)?
Thermo Fisher Scientific (TMO) reported life sciences solutions — operating income (loss) of $1.04B in Q2 2026.
How has Thermo Fisher Scientific's life sciences solutions — operating income (loss) changed year-over-year?
Thermo Fisher Scientific's life sciences solutions — operating income (loss) increased by 13.2% year-over-year, from $920M to $1.04B.
What is the long-term trend for Thermo Fisher Scientific's life sciences solutions — operating income (loss)?
Over 4 years (2021 to 2025), Thermo Fisher Scientific's life sciences solutions — operating income (loss) has grown at a -16.7% compound annual growth rate (CAGR), from $7.82B to $3.77B.
What does life sciences solutions — operating income (loss) mean?
The profit generated by the Life Sciences Solutions segment after deducting all operating expenses, including COGS, SG&A, and R&D, from total revenue. It measures the core profitability of the segment's business activities.

Ask your AI about Thermo Fisher Scientific's life sciences solutions — operating income (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude